Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class...

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Major histocompatibility complex (MHC) class II molecules are vital for immune responses.
• Class II transactivator (CIITA) is known to be essential for MHC class II gene expression in B cells.
• Deficiency in CIITA leads to hereditary MHC class II deficiency.

Purpose of the Study:

• To investigate the role of CIITA in inducible MHC class II gene expression.
• To elucidate the signaling pathway involved in CIITA induction by interferon-gamma (IFN-gamma).
• To determine if CIITA is the primary regulatory factor for inducible class II gene expression.

Main Methods:

• Investigating CIITA expression kinetics relative to MHC class II mRNA upon IFN-gamma treatment.
• Assessing the requirement of new protein synthesis for CIITA and MHC class II gene induction.
• Examining the role of JAK1 protein tyrosine kinase activity in CIITA induction.
• Evaluating the sufficiency of CIITA expression in activating class II genes without IFN-gamma.

Main Results:

• CIITA expression is inducible by IFN-gamma and precedes MHC class II mRNA induction.
• CIITA mRNA induction does not require new protein synthesis, but MHC class II transcription does.
• JAK1 kinase activity is necessary for IFN-gamma-induced CIITA expression.
• CIITA expression alone can activate MHC class II genes, indicating it's a major regulatory factor.

Conclusions:

• CIITA is a key component of the IFN-gamma signaling pathway leading to MHC class II gene activation.
• CIITA acts as the major regulatory factor for inducible MHC class II gene expression.
• CIITA is the previously identified IFN-inducible, cycloheximide-sensitive factor required for MHC class II gene induction.